Experts will address the growing challenges in dementia treatment and explore ways to optimise pathways between primary and secondary care
Dementia and Alzheimer's disease remained the leading cause of death in England and Wales in 2023, maintaining the pre-pandemic trend, according to the latest data from the Office for National Statistics (ONS).
The figures reveal that there were 66,876 deaths with an underlying cause of dementia and Alzheimer's disease, accounting for 11.6% of all deaths registered that year.
In response to this growing health concern, Luye Pharma is hosting a free special educational webinar on 6 November 2024 (timing: 18:30 - 20:00) for healthcare professionals.
Titled "Treating Dementia in 2024: Optimising Pathways Between Primary and Secondary Care," the online session will focus on addressing the ever-increasing challenges in dementia treatment and how to optimise pathways between primary and secondary care.
The webinar will feature expert speakers from the field of dementia care, including Dr. Jill Rasmussen, Primary Care Specialist in dementia, mental health, and intellectual disabilities; Delia Bashara, Consultant Pharmacist for the Mental Health of Older Adults and Dementia at South London and Maudsley NHS Foundation Trust; and Khaleel Loonat, Senior Clinical Pharmacist and Advanced Clinical Practitioner.
Dr. Rasmussen will cover "Issues and Challenges in Managing People with Dementia: Focus on Pathways and Treatments," Delia Bashara will speak on "Dementia Pathways in Secondary Care," and Khaleel Loonat will discuss "Dementia Care: The Use of Transdermal Patches in Primary Care."
The session aims to provide valuable guidance on managing dementia within the current healthcare environment.
Luye Pharma, specializing in diseases of the central nervous system (CNS), has developed Zeyzelf, a twice-weekly transdermal rivastigmine patch for treating Alzheimer’s dementia.
This webinar presents an opportunity for healthcare professionals to learn more about managing and treating dementia.
You can register for the event at the following link: https://hcpconnect-uniphar.com/treating-dementia-in-2024/
Nearly 1 million people in the UK are estimated to have dementia. In hospitals, one in four beds is occupied by individuals over the age of 65 who are living with dementia. Projections suggest that by 2040, up to 1.7 million people could be living with the condition in England and Wales.
